348 related articles for article (PubMed ID: 27615506)
1. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
3. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
5. BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.
Helanterä I; Salmela K; Kyllönen L; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Koskinen P; Lautenschlager I
Clin Transplant; 2012; 26(6):E596-601. PubMed ID: 23083418
[TBL] [Abstract][Full Text] [Related]
6. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
7. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
[TBL] [Abstract][Full Text] [Related]
9. High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.
Kim H; Yu H; Baek CH; Han DJ; Park SK
Transpl Infect Dis; 2016 Dec; 18(6):844-849. PubMed ID: 27622599
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
11. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
[TBL] [Abstract][Full Text] [Related]
12. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
14. Prospective monitoring of BK virus replication in renal transplant recipients.
Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
[TBL] [Abstract][Full Text] [Related]
15. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
[TBL] [Abstract][Full Text] [Related]
16. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
[TBL] [Abstract][Full Text] [Related]
17. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
18. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
Imlay H; Whitaker K; Fisher CE; Limaye AP
Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
[TBL] [Abstract][Full Text] [Related]
20. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
